Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for detecting volatile components in pharmaceutical preparation

A technology of volatile components and detection methods, which is applied in the field of detection and analysis of pharmaceutical components, can solve the problems that the internal quality of traditional Chinese medicine cannot be effectively evaluated, qualitatively, and the ability to identify structures is poor, and the separation of complex compounds cannot be achieved, so as to reduce errors and improve Accuracy and precision, effects of avoiding contamination

Active Publication Date: 2020-11-10
SHANDONG BUCHANG PHARMA
View PDF4 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the implementation standard of this product is the State Food and Drug Administration standard WS 3 -065(Z-010)-2003(Z), but its quality testing method is thin layer identification (TLC) of red ginseng, ephedra, psoralen, epimedium and salvia miltiorrhiza, and the single index component of ginsenoside molecular formula Quality control, the method is simple and elementary, and the detection components are few, so the existing detection can not achieve effective evaluation of the internal quality of the traditional Chinese medicine of the present invention, and more in-depth research is needed
[0003] Gas chromatography is a chromatographic technique that can gradually separate complex chemical components in Chinese patent medicines, but its ability to characterize and identify structures is poor; when combined with mass spectrometry, it has a strong ability to identify unknown compound structures, with high sensitivity and rapid detection , but mass spectrometry itself has the disadvantage of being unable to separate complex compounds, so high-purity samples are required for the identification of unknown compounds

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for detecting volatile components in pharmaceutical preparation
  • Method for detecting volatile components in pharmaceutical preparation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] 1 Experimental materials

[0034] 1.1 Instrument

[0035] TQ8040 GC-MS gas chromatography-mass spectrometer (Shimadzu Corporation, Japan), GC-MS solution chromatographic workstation and NIST14 LIBRARY database (SHIMMADZU Corporation); Sartorius BP211D analytical balance (Sartorius Corporation, USA).

[0036] 1.2 Experimental method

[0037] 1.2.1 Sample preparation

[0038] Precisely measure 5 mL of Shenxian Shengmai oral liquid, put it into a 20 mL headspace sampling bottle, quickly press the cap to seal the bottle mouth, put it into the headspace automatic sampling system AOC-6000, and inject it into the chromatograph for analysis.

[0039] 1.2.2 HS-GC-MS analysis

[0040] ⑴ Headspace conditions:

[0041] Sample vial heating temperature: 70°C; incubation time: 30min; quantitative loop heating temperature: 80°C; draw sample volume: 1mL.

[0042] (3) GC conditions:

[0043] Chromatographic column: HP-5MS (60m*0.25mm, film thickness 0.25um); sample injection method...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a method for detecting volatile components in a medicinal preparation, which adopts an HS-GC / MS (headspace-gas chromatography / mass spectrometry) method to simultaneously detect22 material components including methyl eugenol, safrole, 3, 5-dimethoxytoluene, 1, 2, 3-trimethoxy-5-methyl benzene, myristyl ether, elemenin, 2-Undecenal, 9-decenal, tetradecanoic acid, borneol, isoborneol, palmitic acid, oleic acid, beta-sitosterol, triundecane, 2,3-dihydro-3,5-dihydroxy-6-methyl-4-hydropyrone, 1-iodododecane, caryophyllene, caryophyllene oxide, isopsoralen, tonic Osteostatin,bakuchiol. The detection method can achieve the effect of comprehensively detecting the internal quality of the medicine, so that the safety and effectiveness of the medicine use of the product are ensured.

Description

technical field [0001] The invention relates to the field of detection and analysis of pharmaceutical components, in particular to a detection method for volatile components in pharmaceutical preparations. Background technique [0002] The pharmaceutical preparation of the present invention is composed of red ginseng, epimedium, psoralen, medlar, ephedra, asarum, salvia miltiorrhiza and leeches. The pharmaceutical preparation is a marketed product, and the manufacturer is Shandong Buchang Pharmaceutical Co., Ltd. The name of the marketed product is Shenxian Shengmai Oral Liquid. It is used for yang-deficiency and delayed pulse. Symptoms include delayed pulse, pulse knot, palpitation, and chest tightness. , chills, cold limbs, weak waist and knees, shortness of breath, fatigue or dizziness, dull tongue or scalloped tongue, or ecchymosis or petechiae on the tongue, which is equivalent to mild to moderate sinus node bradycardia (heart rate> 50 beats) And mild sick sinus syn...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N30/02G01N30/06G01N30/72
CPCG01N30/02G01N30/06G01N30/72
Inventor 刘峰黄壮壮孙宇宏刘宇栋许刚彭修娟贺敬霞
Owner SHANDONG BUCHANG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products